Korean J Endocr Surg.  2014 Jun;14(2):81-84.

Clinical Characteristics of Papillary Carcinomas with Other Benign Pathologies

Affiliations
  • 1Department of Surgery, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Korea. reallydong@hanmail.net

Abstract

PURPOSE
Thyroid papillary carcinoma is the most common endocrine tumor. There are many known factors affecting the pathophysiology of papillary carcinomas. In this study, we attempted to determine the clinical characteristics of papillary carcinomas with other benign pathologies.
METHODS
From May 2007 to December 2012, a total of 994 patients underwent thyroidectomy and were diagnosed as papillary carcinomas. Retrospective study was performed using medical records. We categorized them according to five groups depending on associated benign disease, Papillary carcinoma with Graves disease (Group 1), Multinodular goiter (Group 2), Hashimoto thyroiditis (Group 3), Multinodular goiter and Hashimoto thyroiditis (Group 4), and Papillary carcinoma only (Group 5), and we performed a comparison analysis.
RESULTS
T and N stage of group 2 were lower than those of group 5 and T stage of group 3 was lower than that of group 4. T and N stage of group 4 were lower than those of group 5 and extrathyroidal extension rate of group 4 was lower than that of group 5.
CONCLUSION
Papillary carcinomas have variable clinical characteristics according to underlying benign thyroid disease. Conduct of advanced research regarding the mechanisms of the effect of benign thyroid disease on papillary carcinomas is needed.

Keyword

Papillary carcinoma; Benign thyroid disease

MeSH Terms

Carcinoma, Papillary*
Goiter
Graves Disease
Hashimoto Disease
Humans
Medical Records
Pathology*
Retrospective Studies
Thyroid Diseases
Thyroid Gland
Thyroidectomy
Full Text Links
  • KJES
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr